Cadrenal Therapeutics, Payables Turnover Over Time

Stocks . USA . 
Stock . Cadrenal Therapeutics, Common
CVKD Stock   19.09  1.64  9.40%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cadrenal Therapeutics, Performance and Cadrenal Therapeutics, Correlation.
  
As of March 15, 2025, Payables Turnover is expected to decline to 0.01.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cadrenal Therapeutics,. If investors know Cadrenal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cadrenal Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.73)
Return On Assets
(0.71)
Return On Equity
(1.25)
The market value of Cadrenal Therapeutics, is measured differently than its book value, which is the value of Cadrenal that is recorded on the company's balance sheet. Investors also form their own opinion of Cadrenal Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Cadrenal Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cadrenal Therapeutics,'s market value can be influenced by many factors that don't directly affect Cadrenal Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
Please note, there is a significant difference between Cadrenal Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Cadrenal Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cadrenal Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:
Apply

Cross Equities Payables Turnover Analysis

Compare Cadrenal Therapeutics, and related stocks such as Mineralys Therapeutics,, Structure Therapeutics, and Centessa Pharmaceuticals Payables Turnover Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
Inventory TurnoverNet Income Per Share
Days Of Inventory On HandPayables Turnover
Sales General And Administrative To RevenueAverage Inventory
Research And Ddevelopement To RevenueCapex To Revenue
Cash Per SharePocfratio
Interest CoveragePayout Ratio
Capex To Operating Cash FlowPfcf Ratio
Days Payables OutstandingNet Current Asset Value
Income QualityRoe
Tangible Asset ValueEv To Operating Cash Flow
Pe RatioReturn On Tangible Assets
Ev To Free Cash FlowEarnings Yield
Intangibles To Total AssetsNet Debt To E B I T D A
Current RatioTangible Book Value Per Share
Receivables TurnoverGraham Number
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D ARoic
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
2010201120122013201420152016201720182019202020212022202320242025
MLYS0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
GPCR0.01310.01310.01310.01310.01310.01310.01310.01310.01310.01310.01310.07650.10370.20020.180.19
CNTA0.00470.00470.00470.00470.00470.00470.00470.00470.00470.00470.00470.00470.00950.00950.00850.0056
NVCT12.187112.187112.187112.187112.187112.187112.187112.187112.187112.187112.187112.18716.60968.26319.59.92
SNTI12.133712.133712.133712.133712.133712.133712.133712.133712.133712.133717.45730.58032.86134.19524.828.2
FHTX0.18820.18820.18820.18820.18820.18820.18820.18820.18820.521415.68341.96780.003617.522215.7716.56
QNRX0.15260.15260.15260.15260.15260.15260.25540.21250.52964.96360.11280.11280.17110.19650.180.17
IKNA17.197217.197217.197217.197217.197217.197217.197217.197217.197226.671721.134319.76010.97180.49370.570.54
HCWB1.07521.07521.07521.07521.07521.07521.07521.07521.07521.07522.43042.43043.37290.36990.430.4
XCUR15.943315.943315.943315.943315.943315.943326.83512.46928.23810.661517.19940.52125.14130.87251.00.95
CINGW0.09440.09440.09440.09440.09440.09440.09440.09440.09440.09440.86393.05430.81590.11210.130.12
SABS0.37090.37090.37090.37090.37090.37090.37090.37090.37090.37090.37090.37090.89473.95943.563.74
ANEB0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
MNPR0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
ANTX0.03630.03630.03630.03630.03630.03630.03630.03630.03630.03630.03630.03630.03630.03630.03270.029
IKT1.96021.96021.96021.96021.96021.96021.96024.96633.8222.54840.519410.42330.005821.05618.9519.9
PMVP0.32560.32560.32560.32560.32560.32560.32560.32560.32560.13680.19790.40170.2170.38830.350.22

Cadrenal Therapeutics, and related stocks such as Mineralys Therapeutics,, Structure Therapeutics, and Centessa Pharmaceuticals Payables Turnover description

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

My Equities

My Current Equities and Potential Positions

View AllNext
Cadrenal Therapeutics, Common
CVKD
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationFlorida; U.S.A
ExchangeNASDAQ Exchange
null 19.09
When determining whether Cadrenal Therapeutics, is a strong investment it is important to analyze Cadrenal Therapeutics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cadrenal Therapeutics,'s future performance. For an informed investment choice regarding Cadrenal Stock, refer to the following important reports:
How To Invest In Cadrenal
Details
Is Cadrenal Stock a good investment?
Details
What is Cadrenal Therapeutics,'s Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out Cadrenal Therapeutics, Performance and Cadrenal Therapeutics, Correlation.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Cadrenal Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Overlap Analysis
View
Forecast Models
View
Price Shifting
View
Volatility Indicators
View
Value Movement
View
A focus of Cadrenal Therapeutics, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cadrenal Therapeutics, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY